P David Schenkein
Affiliations
- Director at Prime Medicine Inc. (PRME), 2025-06-05
- Director at Denali Therapeutics Inc. (DNLI), 2025-06-05
- Director at Regeneron Pharmaceuticals Inc. (REGN), 2025-01-06
- Director at Agios Pharmaceuticals Inc. (AGIO), 2024-06-24
- at Bluebird Bio Inc. (BLUE), 2020-06-22
- Director at Foundation Medicine Inc. (FMI), 2016-06-20
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AGIO | $31.00 | 8,064 | $249,984.00 | 97,567 | 2019-11-13 | Filing |
| BLUE | $85.00 | 1,176 | $99,960.00 | 1,176 | 2014-12-19 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| DNLI | $32.87 | 32,312 | $1,062,095.44 | 9,220 | 2024-11-11 | Filing |
| DNLI | $32.09 | 27,129 | $870,569.61 | 41,532 | 2024-11-11 | Filing |
| AGIO | $34.89 | 57,471 | $2,005,163.19 | 122,854 | 2024-02-27 | Filing |
| AGIO | $33.60 | 11,858 | $398,428.80 | 122,854 | 2024-02-27 | Filing |
| AGIO | $33.19 | 20,411 | $677,441.09 | 122,854 | 2024-02-26 | Filing |